INTANGIBLE ASSETS

3 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS

INTANGIBLE ASSETS

The following table reflects the gross carrying amounts and net book values of intangible assets as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands): 

		March 31, 2023						December 31, 2022
	Remaining Useful Life  (In years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
Products rights:
INDOCIN	9.1	$	154,100	$	(36,705)	$	117,395	$	154,100	$	(33,495)	$	120,605
Otrexup	6.7	44,086		(6,888)		$	37,198	44,086		(5,511)		38,575
Sympazan	11.6	14,550		(505)		$	14,045	14,550		(202)		14,348
SPRIX	4.1	39,000		(15,926)		$	23,074	39,000		(14,532)		24,468
Total Intangible Assets		$	251,736	$	(60,024)	$	191,712	$	251,736	$	(53,740)	$	197,996

Amortization expense was $6.3 million and $8.5 million for the three months ended March 31, 2023 and 2022, respectively.

The following table reflects future amortization expense the Company expects for its intangible assets (in thousands): 

Year Ending December 31,	Estimated Amortization Expense
2023 (remainder)	18,852
2024	25,136
2025	25,136
2026	25,136
2027	21,747
Thereafter	75,705
Total	$	191,712